A Spoonful Of Kids’ Medicine Makes The Profits Go Up
Even as drug pricing issues continue to draw scrutiny, federal safety regulations and incentives offer drug companies a new avenue to get a sweet return on their development costs.
Health Industry
2,601-2,620 of 4,002 results
-
-
Drugmakers Dramatically Boosted Lobbying Spending In Trump’s First Quarter
With high drug prices creating widespread controversy, top pharmaceutical companies and their trade group vastly increased their lobbying spending on Capitol Hill.
-
Marathon Pharmaceutical Drops Out Of PhRMA Following Drug Price Controversy
Two companies that faced criticism for high-priced drugs, Marathon and Mallinckrodt, have dropped out of the PhRMA trade association.
-
What Doesn’t Kill You Can Maim: Unexpected Injuries From Opioids
Doctors are beginning to pay attention to injuries, such as brain damage or kidney failure, that can afflict people who survive an overdose.
-
For Doctors, A Clamp Down On Visas Could Have An Uneven Effect In The U.S.
New research shows that physicians getting H-1B visas account for just over 1 percent of all doctors, but some areas are much more likely to be seeking their services.
-
With Drug Costs In Crosshairs, Health Firms Gave Generously To Trump’s Inauguration
Led by Pfizer and Amgen, about 10 health care firms contributed to President Donald Trump’s inauguration, which earned them entry into private events with the president and vice president.
-
Letters to the Editor
Readers: Training Patients To Advocate For Their Illnesses Is ‘A Virtue Not A Sin’
Kaiser Health News gives readers a chance to respond, react and comment on our stories.
-
California Hospitals Lose Ground In Quality Of Care, Report Card Shows
The nonprofit Leapfrog Group shows nearly half of California hospitals got a grade of C, D or F in patient safety measures — an increase from two years ago.
By Chad Terhune -
Nonprofit Linked To PhRMA Rolls Out Campaign To Block Drug Imports
The advocacy group behind an expensive media blitz opposing Canadian drug imports has deep ties to the drug industry’s largest trade group.
By Emily Kopp and Rachel Bluth -
Sen. Grassley Demands Scrutiny Of Medicare Advantage Plans
The powerful chairman of the Senate Judiciary Committee wants the Centers for Medicare and Medicaid Services to explain $125 million in overcharges by insurers.
By Fred Schulte -
Repeal & Replace Watch
Repeal, Replace … Revise: Your Guide To How A Trump Proposal Might Change ACA Insurance
Even though the GOP health plan is stalled by intraparty negotiations, some big insurance changes are still in the works.
-
In Remote Idaho, A Tiny Facility Lights The Way For Stressed Rural Hospitals
In a region where bears outnumber people, a small medical facility sets a modern example for rural hospitals on life support.
By Anna Gorman -
California Presses Forward In Fight To Regulate Pharma
Such efforts have previously failed in the face of opposition from the drug industry, which questions their effectiveness and contends prices reflect research and development costs.
-
The Orphan Drug Machine
Drugmakers Help Turn Patients With Rare Diseases Into D.C. Lobbyists
Amplifying the "patient voice," those with the rarest afflictions are trained to become powerful advocates for new drugs and legislation that would help the industry.
-
Repeal & Replace Watch
Death By 1,000 Cuts: How Republicans Can Still Alter Your Coverage
There are many ways beyond legislative repeal for the Trump administration and congressional Republicans to unravel the Affordable Care Act.
By Jay Hancock -
Repeal & Replace Watch
Where There’s Willingness, There’s A Way For Congress And Trump To Fix Health Law
After the collapse of the Republican replacement plan, there may be a way to find consensus and repair the law.
By Julie Rovner -
Trump’s Effort To Lure Consumers To Exchanges Could Bring Skimpier Plans
The changes proposed by the administration for the health law marketplaces in 2018 could increase customers’ out-of-pocket costs and reduce the amount they receive in premium tax credits.
-
Also Made In Mexico: Lifesaving Devices
The medical supply industry makes a particularly revelatory case study of the difficulties of untangling global trade.
By Sarah Varney -
‘The Trump Of Georgia’ Goes To Washington
With high-level connections in the Capitol, Parker "Pete" Petit aims to resolve regulatory issues that have haunted his wound care company.
-
California Doctors Again Press For More Money To Treat Poor Patients
They want the state’s new tobacco tax to help pay for a raise in Medicaid rates, but so far Gov. Jerry Brown has other plans for that money.